Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
- PMID: 7705663
- DOI: 10.1101/gad.9.7.882
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
Abstract
By crossing mice that carry a null allele of p53 with transgenic mice that develop mammary adenocarcinomas under the influence of a Wnt-1 transgene, we have studied the consequences of p53 deficiency in mammary gland neoplasia. In Wnt-1 transgenic mice homozygous for the p53 null allele, tumors appear at an earlier age than in animals heterozygous or wild-type at the p53 locus. About half of the tumors arising in p53 heterozygotes exhibit loss of the normal p53 allele, implying selection for p53-deficient cells. Mammary tumors lacking p53 display less fibrotic histopathology and increased genomic instability with aneuploidy, amplifications, and deletions, as detected by karyotype analysis and comparative genomic hybridization. In one tumor, the amplified region of chromosome 7 had an ectopically expressed int-2/FGF3 proto-oncogene, a gene known to cooperate with Wnt-1 in the production of mammary tumors. These findings favor a model in which p53 deficiency relaxes normal restraints on chromosomal number and organization during tumorigenesis.
Similar articles
-
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.Genes Dev. 2003 Feb 15;17(4):488-501. doi: 10.1101/gad.1051603. Genes Dev. 2003. PMID: 12600942 Free PMC article.
-
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model.Prog Clin Biol Res. 1996;395:1-11. Prog Clin Biol Res. 1996. PMID: 8895979 Review. No abstract available.
-
Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.Oncogene. 2000 Dec 7;19(52):5988-96. doi: 10.1038/sj.onc.1203993. Oncogene. 2000. PMID: 11146550
-
Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.Mol Cell Biol. 1992 Jan;12(1):147-54. doi: 10.1128/mcb.12.1.147-154.1992. Mol Cell Biol. 1992. PMID: 1530875 Free PMC article.
-
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.Oncogene. 2000 Feb 21;19(8):1002-9. doi: 10.1038/sj.onc.1203273. Oncogene. 2000. PMID: 10713683 Review.
Cited by
-
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.Cancer Cell. 2012 Jun 12;21(6):793-806. doi: 10.1016/j.ccr.2012.04.027. Cancer Cell. 2012. PMID: 22698404 Free PMC article.
-
pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia.PLoS Biol. 2004 Feb;2(2):E22. doi: 10.1371/journal.pbio.0020022. Epub 2004 Feb 17. PLoS Biol. 2004. PMID: 14966529 Free PMC article. Review.
-
Trp53 regulates Notch 4 signaling through Mdm2.J Cell Sci. 2011 Apr 1;124(Pt 7):1067-76. doi: 10.1242/jcs.068965. J Cell Sci. 2011. PMID: 21402876 Free PMC article.
-
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.Genes Dev. 1998 Dec 1;12(23):3675-85. doi: 10.1101/gad.12.23.3675. Genes Dev. 1998. PMID: 9851974 Free PMC article.
-
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.Mol Cell Biol. 1997 Feb;17(2):723-31. doi: 10.1128/MCB.17.2.723. Mol Cell Biol. 1997. PMID: 9001226 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous